BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND AKT2, PKBBETA, 208, ENSG00000105221, RAC-BETA, P31751, PRKBB
229 results:

  • 1. [Analysis of factors influencing the efficacy and prognosis of surgical treatment for primary malignant pelvic bone tumors].
    Liu WF; Hao L; Li ZY; Jin T; Sun Y; Yang YK; Li Y; Yang FJ; Yu F; Zhang Q; Niu XH
    Zhonghua Zhong Liu Za Zhi; 2024 Apr; 46(4):344-353. PubMed ID: 38644270
    [No Abstract]    [Full Text] [Related]  

  • 2. Factors influencing postoperative visual improvement in 208 patients with tuberculum sellae meningiomas.
    Duan C; Song D; Wang F; Wang Y; Wei M; Fang J; Zhai T; An Y; Zuo Y; Hu Y; Li G; Yu Z; Guo F
    Acta Neurochir (Wien); 2024 Mar; 166(1):140. PubMed ID: 38491189
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Clinical spectrum and clinicopathological correlation of pediatric orbital tumors: 20 years' experience from a tertiary eye care center.
    Vijay V; Alam MS; Subramanian N; Krishnakumar S; Biswas J; Mukherjee B
    Indian J Ophthalmol; 2024 Feb; 72(2):249-257. PubMed ID: 38099389
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Peri-implant Parameters of Dental Implants Inserted in Prefabricated Microvascular Fibular Flaps: A Retrospective Study.
    Wiesli MG; Fankhauser-De Sousa S; Metzler P; Rohner D; Jaquiéry C
    Int J Oral Maxillofac Implants; 2023 Dec; 38(6):1151-1160. PubMed ID: 38085746
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Charcot neuroarthropathy in persons with diabetes: It's time for a paradigm shift in our thinking.
    Wukich DK; Frykberg RG; Kavarthapu V
    Diabetes Metab Res Rev; 2024 Mar; 40(3):e3754. PubMed ID: 38069459
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Adjacent tooth migration after maxillary first molar loss in patients with sinus augmentation: A retrospective research.
    Zhao F; Shi L; Huang Y; Wang Y; Yu M; Wang H
    Clin Implant Dent Relat Res; 2023 Dec; 25(6):1080-1090. PubMed ID: 37496294
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Prognosis prediction of icotinib as targeted therapy for advanced EGFR-positive non-small cell lung cancer patients.
    Tan X; Wang S; Xia H; Chen H; Xu J; Meng D; Wang Z; Li Y; Yang L; Jin Y
    Invest New Drugs; 2023 Jun; 41(3):463-472. PubMed ID: 37140694
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Intestinal permeability in patients undergoing stem cell transplantation correlates with systemic acute phase responses and dysbiosis.
    Wang YM; Abdullah S; Luebbering N; Langenberg L; Duell A; Lake K; Lane A; Hils B; Vazquez Silva O; Trapp M; Nalapareddy K; Koo J; Denson LA; Jodele S; Haslam DB; Faubion WA; Davies SM; Khandelwal P
    Blood Adv; 2023 Sep; 7(17):5137-5151. PubMed ID: 37083597
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Comparative Anatomic Study Between Intradural Suboccipital Retrosigmoid and Extradural Transzygomatic Middle Fossa Approaches to Expose the Trigeminal Nerve.
    Rassi MS; Ribas ESC; Coelho VPM; Essayed WI; Al-Mefty O; Figueiredo EG
    World Neurosurg; 2023 Jul; 175():e745-e753. PubMed ID: 37037369
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Intercontinental comparison of women with breast cancer treated by oncologists in Europe, Asia, and Latin America: a retrospective study of 99,571 patients.
    Kadys A; Gremke N; Schnetter L; Kostev K; Kalder M
    J Cancer Res Clin Oncol; 2023 Aug; 149(10):7319-7326. PubMed ID: 36920565
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. A novel nomogram to stratify quality of life among advanced cancer patients with spinal metastatic disease after examining demographics, dietary habits, therapeutic interventions, and mental health status.
    Li Y; Long Z; Wang X; Lei M; Liu C; Shi X; Liu Y
    BMC Cancer; 2022 Nov; 22(1):1205. PubMed ID: 36424551
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Zanubrutinib Versus Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma: Interim Analysis of a Randomized Phase III Trial.
    Hillmen P; Eichhorst B; Brown JR; Lamanna N; O'Brien SM; Tam CS; Qiu L; Kazmierczak M; Zhou K; Šimkovič M; Mayer J; Gillespie-Twardy A; Shadman M; Ferrajoli A; Ganly PS; Weinkove R; Grosicki S; Mital A; Robak T; Österborg A; Yimer HA; Salmi T; Ji M; Yecies J; Idoine A; Wu K; Huang J; Jurczak W
    J Clin Oncol; 2023 Feb; 41(5):1035-1045. PubMed ID: 36395435
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Efficacy and Safety of Radium-223 for Castration-resistant Prostate cancer With bone Metastasis Before and After Docetaxel.
    Okabe KO; Terada N; Shirakawa T; Onizuka C; Kimura T; Yamashita Y; Otuka I; Ueno T; Nagano M; Takamori H; Mukai S; Kamoto T
    Anticancer Res; 2022 Oct; 42(10):4981-4987. PubMed ID: 36191975
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Osteosarcoma and causes of death: A report of 1520 deceased patients from the Cooperative Osteosarcoma Study Group (COSS).
    Bielack SS; Blattmann C; Borkhardt A; Csóka M; Hassenpflug W; Kabíčková E; Kager L; Kessler T; Kratz C; Kühne T; Kevric M; Lehrnbecher T; Mayer-Steinacker R; Mettmann V; Metzler M; Reichardt P; Rossig C; Sorg B; von Luettichau I; Windhager R; Hecker-Nolting S
    Eur J Cancer; 2022 Nov; 176():50-57. PubMed ID: 36191386
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Measurable residual disease (MRD) status before allogeneic hematopoietic cell transplantation impact on secondary acute myeloid leukemia outcome. A Study from the Acute Leukemia Working Party (ALWP) of the European society for Blood and Marrow Transplantation (EBMT).
    Maffini E; Labopin M; Beelen DW; Kroeger N; Arat M; Wilson KMO; Bay JO; Ganser A; Martin H; Passweg J; Kottaridis PD; Yakoub-Agha I; Porras RP; Wagner EM; Esteve J; Lanza F; Nagler A; Mohty M
    Bone Marrow Transplant; 2022 Oct; 57(10):1556-1563. PubMed ID: 35835997
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Comparison of skeletal segmentation by deep learning-based and atlas-based segmentation in prostate cancer patients.
    Motegi K; Miyaji N; Yamashita K; Koizumi M; Terauchi T
    Ann Nucl Med; 2022 Sep; 36(9):834-841. PubMed ID: 35773557
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Minimal residual disease-guided stop and start of venetoclax plus ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia (HOVON141/VISION): primary analysis of an open-label, randomised, phase 2 trial.
    Kater AP; Levin MD; Dubois J; Kersting S; Enggaard L; Veldhuis GJ; Mous R; Mellink CHM; van der Kevie-Kersemaekers AF; Dobber JA; Poulsen CB; Frederiksen H; Janssens A; Schjødt I; Dompeling EC; Ranti J; Brieghel C; Mattsson M; Bellido M; Tran HTT; Nasserinejad K; Niemann CU
    Lancet Oncol; 2022 Jun; 23(6):818-828. PubMed ID: 35654052
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Genomic Features of Lung-Recurrent Hormone-Sensitive Prostate cancer.
    Fonseca NM; Van der Eecken K; Herberts C; Verbeke S; Ng SWS; Lumen N; Ritch E; Murtha AJ; Bernales CQ; Schönlau E; Moris L; Van Dorpe J; Annala M; Wyatt AW; Ost P
    JCO Precis Oncol; 2022 Apr; 6():e2100543. PubMed ID: 35507889
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Comparison of open versus minimally invasive surgery in the treatment of thoracolumbar metastases.
    Ntilikina Y; Collinet A; Tigan LV; Fabacher T; Steib JP; Charles YP
    Orthop Traumatol Surg Res; 2022 Jun; 108(4):103274. PubMed ID: 35331924
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Associations between long-term exposure to PM
    Yu P; Xu R; Li S; Coelho MSZS; Saldiva PHN; Sim MR; Abramson MJ; Guo Y
    Environ Pollut; 2022 Jun; 302():119070. PubMed ID: 35231538
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 12.